Fig. 5From: Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictorSubject 2009. A, NG12-1 treatment area (arrows) showing skin blanch 20 min after topical NG12-1 application on Day 4. B, NG12-1 treatment area (arrows) showing reduced radiodermatis on Day 32. The final analysis score was +Back to article page